NYSEARCA:SRXH • US08771Y4026
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SRX HEALTH SOLUTIONS INC (SRXH).
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 54.66M 18.81% | 38.592M -29.40% | 34.975M -9.37% | |
| EBITDA YoY % growth | -18.479M -18.34% | -10.969M 40.64% | -5.837M 46.79% | |
| EBIT YoY % growth | -20.169M -16.73% | -12.647M 37.29% | -5.967M 52.82% | |
| Operating Margin | -36.90% | -32.77% | -17.06% | |
| EPS YoY % growth | N/A 99.22% | N/A 37.50% | N/A 273.33% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
7 analysts have analysed SRXH and the average price target is 10.2 USD. This implies a price increase of 8400% is expected in the next year compared to the current price of 0.12.
SRX HEALTH SOLUTIONS INC (SRXH) will report earnings on 2026-03-25.